Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
Trials
View this publicationTrials
View this publicationBriefings in bioinformatics
View this publicationBMC pregnancy and childbirth
View this publicationThe Science of the total environment
View this publicationBiology
View this publicationJAMA dermatology
View this publicationEuropean journal of orthodontics
View this publicationInternational journal of environmental research and public health
View this publicationCancers
View this publicationAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica
View this publication